The elevated levels of interleukin-13 (IL-13) and the protein periostin seen in the whole blood samples taken from patients who had uncontrolled prurigo nodularis (PN) compared with a group of ...

One potential cause of the variability in response to treatment is heterogeneity in the role of interleukin-13 expression in the clinical asthma phenotype. We hypothesized that anti–interleukin ...

Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils ...

Ebglyss is a targeted interleukin-13 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis. It can be used with or without topical corticosteroids. Eli Lilly and Company ...

Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking ...

The researchers evaluated the correlation of interleukin-13 (IL-13) expression with AD biomarkers in lesional skin samples from 27 cases with moderate to severe AD and 38 healthy controls.

Significantly greater reductions in the mean esophageal eosinophil counts occurred in patients who received the humanized anti-interleukin 13 antibody, RPC4046. SEATTLE — RPC4046, a humanized ...

announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody asset from AbbVie (ABBV). The asset, designated ...

announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody asset from AbbVie (NYSE: ABBV). "We are honored that ...